Haidong Liang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Nlrp Inflammasome

Long Noncoding Rna

Top Venues

Molecular medicine (Cambridge, Mass.)

Translational cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Shan Jiang, Ziang Zheng, Bo Yuan, Rushan Yan, Qijun Yao, Haoran Chen, Yongxun Zhang, Yue Lei, Haidong Liang
MFAP2 induces epithelial-mesenchymal transformation of osteosarcoma cells by activating the Notch1 pathway. Translational cancer research 13 (6) (2024)
Ziang Zheng, Xinghan Zhao, Bo Yuan, Shan Jiang, Rushan Yan, Xiaowei Dong, Qijun Yao, Haidong Liang
Soy isoflavones induces mitophagy to inhibit the progression of osteosarcoma by blocking the AKT/mTOR signaling pathway. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Qijun Yao, Yue Lei, Yongxu Zhang, Haoran Chen, Xiaowei Dong, Zhiqiang Ye, Haidong Liang
EZH2-H3K27me3-Mediated Epigenetic Silencing of DKK1 Induces Nucleus Pulposus Cell Pyroptosis in Intervertebral Disc Degeneration by Activating NLRP3 and NAIP/NLRC4. Inflammation (2024)
Ziang Zheng, Xinghan Zhao, Bo Yuan, Shan Jiang, Rushan Yan, Xiaowei Dong, Qijun Yao, Haidong Liang
Soy isoflavones induces mitophagy to inhibit the progression of osteosarcoma by blocking the AKT/mTOR signaling pathway. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Shan Jiang, Ziang Zheng, Bo Yuan, Rushan Yan, Qijun Yao, Haoran Chen, Yongxun Zhang, Yue Lei, Haidong Liang
MFAP2 induces epithelial-mesenchymal transformation of osteosarcoma cells by activating the Notch1 pathway. Translational cancer research 13 (6) (2024)
Ziang Zheng, Xinghan Zhao, Bo Yuan, Shan Jiang, Rushan Yan, Xiaowei Dong, Qijun Yao, Haidong Liang
Soy isoflavones induces mitophagy to inhibit the progression of osteosarcoma by blocking the AKT/mTOR signaling pathway. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Ziang Zheng, Xinghan Zhao, Bo Yuan, Shan Jiang, Rushan Yan, Xiaowei Dong, Qijun Yao, Haidong Liang
Soy isoflavones induces mitophagy to inhibit the progression of osteosarcoma by blocking the AKT/mTOR signaling pathway. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)